News Search Results
Apr 09, 2025, 07:21 ET Oxolife's CEO Agnès Arbat receives prestigious EU Women Innovators Prize
completed a General Management Programme at IESE Business School. She is a guest professor & mentor for the Master's in Pharmaceutical Industry and Biotechnology at UPF and UIC. Oxolife's lead candidate, OXO-001, is a first-in-class non-hormonal drug that acts directly on the endometrium to enhance
More news about: Oxolife
Apr 09, 2025, 07:00 ET Solu Therapeutics Closes $41M Series A Financing and Announces First Patient Dosed in Phase 1 Clinical Trial of STX-0712 in Patients with CMML and Other Advanced Hematologic Malignancies
BOSTON, April 9, 2025 /PRNewswire/ -- Solu Therapeutics, a biotechnology company pioneering therapies to eliminate disease-driving cells in cancer, immunology, and other therapeutic areas, today announced the successful
More news about: Solu Therapeutics
Apr 09, 2025, 05:55 ET FRIDAY INVESTOR DEADLINE: ICON PLC Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
insufficient to shield ICON from the adverse effects of a significant market downturn; (iii) the requests for proposals ICON received from its biotechnology customers during the Class Period were used in substantial part as price discovery tools, and thus were not indicative of underlying client demand;
More news about: Robbins Geller Rudman & Dowd LLP
Apr 09, 2025, 05:20 ET RoboMarkets expands opportunities for retail clients: new stocks, ETFs, and enhanced trading conditions
Similarweb Ltd.Consumer goods & services: Despegar.com Corp, Gambling.com Group Ltd., Zhihu Inc.Healthcare & Biotechnology: Inari Medical Inc., Surmodics Inc., USANA Health Sciences Inc.Financials: BlackRock Resources & Commodities Strategy Trust,
More news about: RoboMarkets Deutschland GmbH
Apr 09, 2025, 05:18 ET RoboMarkets expands opportunities for retail clients: new stocks, ETFs, and enhanced trading conditions
Ltd.Consumer goods & services: Despegar.com Corp, Gambling.com Group Ltd., Zhihu Inc.Healthcare & Biotechnology: Inari Medical Inc., Surmodics Inc., USANA Health Sciences Inc.Financials: BlackRock Resources & Commodities Strategy Trust,
More news about: RoboMarkets Deutschland GmbH
Apr 09, 2025, 03:30 ET Infinitopes Granted Phase I/IIa Clinical Trial Application Approval to Evaluate Precision Vaccine Targeting Early-Stage Oesophageal Cancer
Safety, Tolerability & Anti-tumour activity) About Infinitopes Infinitopes Ltd is now a clinical stage, integrated cancer biotechnology company supported by Cancer Research UK (CRUK) and the University of Oxford. The Company combines two world leading
More news about: Infinitopes
Apr 08, 2025, 20:23 ET ICLR Deadline: ICLR Purchasers Have Opportunity to Lead ICON plc Securities Fraud Lawsuit
were insufficient to shield ICON from the adverse effects of a significant market downturn; (3) the requests for proposals ICON received from its biotechnology customers during the Class Period were used in substantial part as price discovery tools, and thus were not indicative of underlying client demand;
More news about: THE ROSEN LAW FIRM, P. A.
Apr 08, 2025, 17:31 ET TIBSOVO's Continued Success Solidifies Its Position as a Leader in IDH1 Mutant Space | DelveInsight
next-generation sequencing. The demand for more effective and accessible cancer treatments is fueling innovation in both the pharmaceutical and biotechnology sectors, with numerous new drugs and therapies entering clinical trials and moving toward commercialization. As a result, the oncology market is
More news about: DelveInsight Business Research, LLP
Apr 08, 2025, 16:32 ET Gabrielle Denby Joins Rubin and Rudman's Family Law Group
Rubin and Rudman serves national and international companies, including large public companies and closely held businesses; real estate developers; biotechnology, pharmaceutical and medical device makers; regulated industries, public entities and municipalities; insurance companies and their insureds; educational
More news about: Rubin and Rudman
Apr 08, 2025, 12:34 ET Kemin Industries déplore la perte de son cofondateur R.W. Nelson
State of Iowa Economic Impact Award en 1987, le Ernst and Young Entrepreneur Achievement Iowa Award en 1991 et le Iowa Biotechnology Association's Entrepreneur Achievement Biotechnology Award en 2004. Il a été intronisé au Iowa Business Hall of Fame en 2006. R.W. était un leader serviteur qui a
More news about: Kemin Industries
Apr 08, 2025, 12:31 ET Kemin Industries trauert um den Mitbegründer R.W. Nelson
den State of Iowa Economic Impact Award, 1991 den Ernst and Young Entrepreneur Achievement Iowa Award und 2004 den Iowa Biotechnology Association's Entrepreneur Achievement Biotechnology Award. Im Jahr 2006 wurde er in die Iowa Business Hall of Fame aufgenommen. R.W.
More news about: Kemin Industries
Apr 08, 2025, 12:27 ET A Kemin Industries lamenta a perda do cofundador R.W. Nelson
Iowa em 1987, o Prêmio Ernst and Young Entrepreneur Achievement Iowa em 1991 e o Prêmio de Biotecnologia de Empreendedorismo da Iowa Biotechnology Association em 2004. Ele foi introduzido no Iowa Business Hall of Fame em 2006. R.W. foi um líder servidor que construiu a Kemin com base
More news about: Kemin Industries
Apr 08, 2025, 12:01 ET CS Analytical Signs IT System Support Agreement with E-2 Consulting
cGMP, FDA-registered and inspected contract laboratory exclusively designed and dedicated to container and package testing for the pharmaceutical, biotechnology, and medical device industries, is excited to announce that it has partnered with E2 IT Consulting to support the CS Analytical IT environment.
More news about: CS Analytical
Apr 08, 2025, 11:18 ET Kemin Industries Mourns the Loss of Co-Founder R.W. Nelson
of Iowa Economic Impact Award in 1987, the Ernst and Young Entrepreneur Achievement Iowa Award in 1991, and the Iowa Biotechnology Association's Entrepreneur Achievement Biotechnology Award in 2004. He was inducted into the Iowa Business Hall of Fame in 2006. R.W. was a servant leader who built
More news about: Kemin Industries
Apr 08, 2025, 11:04 ET Kemin Industries Mourns the Loss of Co-Founder R.W. Nelson
of Iowa Economic Impact Award in 1987, the Ernst and Young Entrepreneur Achievement Iowa Award in 1991, and the Iowa Biotechnology Association's Entrepreneur Achievement Biotechnology Award in 2004. He was inducted into the Iowa Business Hall of Fame in 2006. R.W. was a servant leader who built
More news about: Kemin Industries
Apr 08, 2025, 10:30 ET US Digital Pathology Market worth US$2.01 billion by 2029 with 13.1% CAGR | MarketsandMarkets™
into pharmaceutical and biotechnology firms, hospital and reference labs, and research and academic institutes. In 2023, pharmaceutical and biotechnology firms accounted for the largest share among end users because of several significant reasons. Pharmaceutical and biotechnology companies rely heavily
More news about: MarketsandMarkets
Apr 08, 2025, 10:30 ET Alternative Protein Market to Reach $55.01 Billion by 2032, Growing at a CAGR of 14.3% from 2025--Exclusive Report by Meticulous Research®
consumption. The increasing adoption of plant-based, vegan, and flexitarian diets is fueling demand for protein-rich alternatives. Innovations in biotechnology and fermentation are enhancing the variety and functionality of alternative proteins, making them more appealing to consumers and food manufacturers.
More news about: Meticulous Market Research Pvt. Ltd.
Apr 08, 2025, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Sana Biotechnology, Inc. and Certain Officers - SANA
April 8, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Sana Biotechnology, Inc. ("Sana" or the "Company") (NASDAQ: SANA) and certain officers. The class action, filed in the United States
More news about: Pomerantz LLP
Apr 08, 2025, 10:00 ET Care Fertility and U-Ploid Biotechnologies Announce Research Collaboration to Improve Egg Quality in Women of Advanced Maternal Age
www.carefertility.com. About U-Ploid Biotechnologies: U-Ploid is a biotechnology company developing first-in-class reproductive health therapeutics to address the global unmet need of age-related fertility decline. The Company's
More news about: U-Ploid Biotechnologies
Apr 08, 2025, 09:40 ET GenScript Biotech Releases 2024 ESG Report, Highlighting Sustainability Practices and Progress
high-potential talent pool to fuel long-term growth. Giving Back to Communities: Advancing Social Responsibility Through Biotechnology: GenScript supports various causes that align with its values and mission, focusing on health, education, and environmental sustainability.
More news about: GenScript Biotech Corporation
Apr 08, 2025, 09:31 ET Amity University Rajasthan Students Shine at Times Fashion Week
Universities Rankings 2025. The University provides students with cutting-edge laboratories for languages, media studies, education, pharmacy, biotechnology, engineering, hotel management, business management, and scientific research, as well as sophisticated facilities for a variety of research projects.
More news about: Amity University Rajasthan
Apr 08, 2025, 09:00 ET BIOTECHBEAUTY LAUNCHES A MICROBIOME-FRIENDLY MAKEUP LINE, BRIDGING BIOTECH-POWERED SKINCARE & HIGH-PERFORMANCE COLOR
BiotechBeauty introduces its revolutionary microbiome-friendly makeup line, seamlessly blending cutting-edge biotechnology with high-performance color. Founded by cosmetic chemist Alanna Tran, this clinically backed brand is redefining
More news about: BiotechBeauty
Apr 08, 2025, 09:00 ET Amacathera Collaborates With Leading Global Pharmaceutical Company To Develop Single-Injection, Long-Acting Biologic Using Its Advanced Hydrogel Delivery Platform, Amacagel™
TORONTO, April 8, 2025 /PRNewswire/ - AmacaThera, a clinical-stage biotechnology company specializing in drug delivery, announced a new pipeline program in collaboration with a leading global pharmaceutical company. Through this
More news about: AmacaThera Inc.
Apr 08, 2025, 09:00 ET Amacathera Collaborates With Leading Global Pharmaceutical Company To Develop Single-Injection, Long-Acting Biologic Using Its Advanced Hydrogel Delivery Platform, Amacagel™
TORONTO, April 8, 2025 /PRNewswire/ -- AmacaThera, a clinical-stage biotechnology company specializing in drug delivery, announced a new pipeline program in collaboration with a leading global pharmaceutical company. Through this
More news about: AmacaThera Inc.
Apr 08, 2025, 08:00 ET ArtBlood Signs MOU with Expression Manufacturing for Large-Scale In Vitro Red Blood Cell Production
ATLANTA, April 8, 2025 /PRNewswire/ -- ArtBlood, a biotechnology company specializing in transfusion blood production, announced that it has signed a Memorandum of Understanding (MOU) with Expression Manufacturing
More news about: Expression Therapeutics, Inc.